Rachel Lynn Holmes, OTR/L Occupational Therapist - Pediatrics Medicare: Medicare Enrolled Practice Location: 8599 N 32nd St Ste 104, Richland, MI 49083 Phone: 269-203-7394 Fax: 269-359-3710 |
Ms. Carol Parker Scharfenberg, MAOTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6684 N 35th St, Richland, MI 49083 Phone: 269-629-4559 |
Hannah Anttila, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 8599 N 32nd St, Ste 104, Richland, MI 49083 Phone: 269-203-7394 Fax: 269-359-3710 |
Rise Therapy & Wellness Llc Occupational Therapist Medicare: Medicare Enrolled Practice Location: 8599 N 32nd St Ste 104, Richland, MI 49083 Phone: 269-203-7394 |
Jessica Seratt, OTRL Occupational Therapist Medicare: Medicare Enrolled Practice Location: 8599 N 32nd St Ste 104, Richland, MI 49083 Phone: 269-203-7394 |
Marie Bell, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 8599 N 32nd St Ste 104, Richland, MI 49083 Phone: 269-203-7394 Fax: 269-359-3710 |
Mrs. Daneel Nicole Bowker, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 11280 E De Ave, Richland, MI 49083 Phone: 517-376-0853 |
Morgan Adams, OTRL Occupational Therapist Medicare: Medicare Enrolled Practice Location: 8599 N 32nd St Ste 104, Richland, MI 49083 Phone: 269-397-2829 |
News Archive
A new study in the UK, by researchers at Imperial College London, The Francis Crick Institute and the University of Glasgow, explores the loss of coronavirus disease 2019 (COVID-19) vaccine efficacy against the virus behind the current pandemic caused by the emergence of newer variants that have undergone mutational escape.
Intermittent fasting is all the rage, but scientific evidence showing how such regimes affect human health is not always clear cut. Now a scientific review in the British Journal of Diabetes and Vascular Disease published by SAGE, suggests that fasting diets may help those with diabetes and cardiovascular disease, alongside established weight loss claims.
The antibacterial ingredient in some soaps, toothpastes, odor-fighting socks, and even computer keyboards is pointing scientists toward a long-sought new treatment for a parasitic disease that affects almost two billion people. Their report on how triclosan became the guiding light for future development of drugs for toxoplasmosis appears in ACS' monthly Journal of Medicinal Chemistry.
Santarus, Inc., a specialty biopharmaceutical company, today announced that its collaboration partner, Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA (SIX: COPN), has completed enrollment of 514 patients in the European Phase III clinical trial to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis.
› Verified 4 days ago